January 27, 2011 -- Boston Scientific has started a China trial of its Promus™ drug eluting stent. The double-blind test will enroll 500 patients in 15 sites across China. The goal of the trial, which is the first that Boston Scientific has conducted entirely within China, is to gain SFDA approval of the device. More details....
